《Nature,2月25日,Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2021-03-01
  • Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population

    Yudibeth Sixto-López, José Correa-Basurto, Martiniano Bello, Bruno Landeros-Rivera, Jose Antonio Garzón-Tiznado & Sarita Montaño

    Scientific Reports volume 11, Article number: 4659 (2021)

    Abstract

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerged coronavirus responsible for coronavirus disease 2019 (COVID-19); it become a pandemic since March 2020. To date, there have been described three lineages of SARS-CoV-2 circulating worldwide, two of them are found among Mexican population, within these, we observed three mutations of spike (S) protein located at amino acids H49Y, D614G, and T573I. To understand if these mutations could affect the structural behavior of S protein of SARS-CoV-2, as well as the binding with S protein inhibitors (cepharanthine, nelfinavir, and hydroxychloroquine), molecular dynamic simulations and molecular docking were employed. It was found that these punctual mutations affect considerably the structural behavior of the S protein compared to wild type, which also affect the binding of its inhibitors into their respective binding site. Thus, further experimental studies are needed to explore if these affectations have an impact on drug-S protein binding and its possible clinical effect.

  • 原文来源:https://www.nature.com/articles/s41598-021-84053-8
相关报告
  • 《2月25日_在墨西哥发现的SARS-CoV-2刺突蛋白自然突变体的结构》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2021-03-01
    • Scientific Reports于2月25日发表了墨西哥国立理工学院等机构的文章“Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population”,描述了在墨西哥人群中发现的SARS-CoV-2刺突蛋白自然突变体的结构。 文章称,迄今为止,SARS-CoV-2在世界范围内流行有三种谱系,其中在墨西哥人群中发现两种谱系。在这些谱系中,研究人员观察到刺突(S)蛋白H49Y、D614G和T573I位点的氨基酸发生的三种突变。为了了解这些突变是否会影响SARS-CoV-2刺突蛋白结构特性,以及与S蛋白抑制剂(千金藤素、奈非那韦、羟氯喹)的结合,研究人员采用了分子动力学模拟和分子对接的方法。研究发现,与野生型相比,这些点状突变在很大程度上影响了S蛋白的结构特性,也影响了其抑制剂与各自结合位点的结合。因此,需要进一步的实验研究来探索这些影响是否对药物与S蛋白结合及其可能的临床效果产生影响。 原文链接:https://www.nature.com/articles/s41598-021-84053-8
  • 《Nature,3月25日,Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2021-03-29
    • Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice Raoul De Gasparo, Mattia Pedotti, […]Luca Varani Nature (2021) Abstract Neutralizing antibodies targeting the receptor binding domain (RBD) of the SARS-CoV-2 Spike (S) are among the most promising approaches against coronavirus disease 2019 (COVID-19)1,2. We developed a bispecific, IgG1-like molecule (CoV-X2) based on two antibodies derived from COVID-19 convalescent donors, C121 and C1353. CoV-X2 simultaneously binds two independent sites on the RBD and, unlike its parental antibodies, prevents detectable S binding to Angiotensin-Converting Enzyme 2 (ACE2), the virus cellular receptor. Furthermore, CoV-X2 neutralizes SARS-CoV-2 and its variants of concern, as well as the escape mutants generated by the parental monoclonals. In a novel animal model of SARS-CoV-2 infection with lung inflammation, CoV-X2 protects mice from disease and suppresses viral escape. Thus, simultaneous targeting of non-overlapping RBD epitopes by IgG-like bispecific antibodies is feasible and effective, combining into a single molecule the advantages of antibody cocktails.